Confidentiality In Clinical Research Paper

Improved Essays
Clinical trials involve the production of large quantities of information that need to be recorded in order to analyze them for adverse events, patient profile, etc. Electronic record keeping has changed the manner in which information about trials and patients are stored and accessed. Electronic records also serve as a means for researchers to access information about previous trials in order to find if there is any data that had been overlooked but might be of use. The terms data and information used here are interchangeable and include numeric data files, qualitative files like interview transcripts, field notes, and research files in audio and video formats among others.
Confidentiality in clinical research in the US is covered by the "Privacy
…show more content…
Early trials may produce some records of data. The results from such data might not be encouraging but pharmaceutical companies routinely cite security concerns and maintain secrecy to prevent them from being exposed. Alternatively, if the early trial data is positive, the sponsors might reveal them earlier and thus bias the regulators into giving approval. Also, patients might want to stop participating in trials if early trial data showed negative results, this can cost sponsors money and require them to search for replacements which can be time-consuming and expensive, to say the least.
Regulators like the Food and Drugs Administration recommended that some secrecy was necessary to be maintained with respect to interim data. This was because they wished for the scientific question of whether the drug is useful or not to be established fully rather than stop the trial on the basis of a small suspect in the safety of the drug. Their positions on the topic have been shown to be tilting towards giving patient safety the first priority by releasing interim data of early trials rather than allowing damaging early trial info from being kept in

Related Documents

  • Improved Essays

    They knew how to contact us! If Dr. Gey wasn't dead, I think I would have killed him myself” (169). We should not make someone feel like this anymore. Therefore, medical research should not be done without the patient’s informed consent even if research proves invaluable for humankind because everyone must have their rights to select what they want to do with their…

    • 1099 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Gone are the days when doctors withheld certain diagnoses or treatment details from patients.” (Argonin). Today, if a doctor were to take anything from a patient without consent, he would be sued by the patient, expelled by the hospital, and hated by many. It is morally and ethically wrong of someone to do such a thing without permission. Not to mention…

    • 797 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    Dr. Sayer was more of a researcher more so than someone who was just doing their job and collecting checks for a living. He did research in neurological lab. He kept trying to help the catatonic patients who were victims an epidemic of encephalitis lethargic. He wanted to find something that would help cure the patients, who were conscious but unable to do massive amount of movements. He wanted to understand how the patients were capable of catching things and noticing a change in their environments while in a catatonic state.…

    • 379 Words
    • 2 Pages
    Improved Essays
  • Decent Essays

    In 1992 FDA introduced the Accelerated Approval Subpart H into the new drug approval process and in 1995 extended its application to oncology drugs. This allows accelerated approval of drugs for serious or life-threatening diseases if they appear to provide a benefit over available therapy based on a surrogate endpoint that is “reasonably likely to predict clinical benefit”. Use of such a surrogate generally allows smaller and quicker trials as the surrogates mature faster than endpoints like Overall Survival (OS), so Subpart H facilitated potential earlier marketing of useful drugs. By 2006 30 oncology drugs, including biologics, had been given accelerated approvals and, from thalidomide for multiple myeloma in May 2006 through nilotinib…

    • 232 Words
    • 1 Pages
    Decent Essays
  • Improved Essays

    For this weeks assignment I chose to discuss the ethical practices of the American Heart Association. “The American Heart Association (AHA) builds their research team on values of Integrity, Excellence, Vision, Dedication, Inclusiveness, and Sensitivity” (AHA, 2011). It is the standard of the AHA to treat human subjects with respect. In addition the AHA treats all tissue and cells derived from experimental subject with the same respect.…

    • 437 Words
    • 2 Pages
    Improved Essays
  • Improved Essays

    This is because it exposes participants to every level of experimental treatments. “It may be difficult to find participants willing to take part in such an experiment” (Bordens & Abbott, 2018, p. 314). Another disadvantage is that it is time consuming and participants can become bored, drained and exhausted when if several hours of their time is needed for the study. A big disadvantage is that you can make errors when dispensing medication/treatments, failing to follow proper instructions on the treatments given, and if a participant passes away during the subject design. This means you must get rid of all the data collected and start over again using new…

    • 431 Words
    • 2 Pages
    Improved Essays
  • Decent Essays

    Dr. Brawley’s experience at National Cancer Institute is very eye-opening. I like the story of CD-4 study in the Chapter 15 The Guillain-Barre Syndrome. As a pharmacy student with interest in clinical research, I understand the importance to get the consent of the patients including not only the possible advantages but also the uncertainty of the risks.…

    • 339 Words
    • 2 Pages
    Decent Essays
  • Improved Essays

    Biosimilar Case Study

    • 1117 Words
    • 5 Pages

    Phase III Multinational Clinical Trials for Biosimilar USFDA and Health Canada have established exclusive approval pathways for biosimilars, they are not identical copies of their originators but needs to show a highly similar structure and similar clinical efficacy, safety and immunogenicity to their approved reference biologics. The main goal is to approve biosimilars are to reduce the cost and make it available to the large population. Biosimilars also undergo for testing at all stages of drug development from analytical, non-clinical, and clinical, which is suggestively more than the small-molecule generic drugs but less requirement than new biologics. The US FDA is authorizing the biosimilars under the Biologic Price Competition and Innovation…

    • 1117 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Opioids In America

    • 906 Words
    • 4 Pages

    When it comes to the regulation of drugs Americans are not informed fully on what the FDA’s actions are. Overall, their job is to ensure the drugs will not cause a large amount of harm but there is a large amount of science they do not test. Richard Deyo, an MD from The Journal of the American Board of Family Medicine, wrote an address that started the FDA’s procedures are lacking by that statement that, “It does not review advertisements before use, assess cost-effectiveness, or regulate surgery (except for devices). Many believe postmarketing surveillance of drugs and devices is inadequate” (Deyo). Important factors like cost-effectiveness are not accounted for which leave families who cannot afford alternatives.…

    • 906 Words
    • 4 Pages
    Improved Essays
  • Great Essays

    Although statistical data and research shows there are healthcare disparities as it relates to minorities, much isn’t done to change negative patterns. However, researchers’ have chosen to examine the healthcare racial inequalities of African Americans. Cultural differences, and racial conscious and unconscious are factors that contribute to the gap in African American health. Therefore, collecting only medical data and physician behaviors towards certain diagnosis, is not enough to determine or conclude that there aren’t any deep rooted unforeseen components that play into racialist thinking by physicians.…

    • 2046 Words
    • 9 Pages
    Great Essays
  • Improved Essays

    Puneet Cheema 12/5/2014 PHIL 355 Professor Stacey Elizabeth Ake Extra Credit Opportunity #1: What is the story of Jessie Gelsinger? What was its impact on the development of gene therapy? In September 1999, Jesse Gelsinger passed away. It is often remembered by many medical researchers despite not really being a household name.…

    • 994 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    Introduction The one of important principle in medical ethics that the information about patient is private and secrecy that relating to that information. Patient confidentiality is a primary part of health care that should be caravel about it . It requires for all health care providers to keep the personal health information about the patient’s private unless the consent release to the information is provided by the patient. The ethics issues surround in patient confidentiality is the one of the important topic that can affected the patient social life if one know the patient and the condition my he inform the rest of the society about patient condition that my make them Socially pariah .I chose this topic because it's the most sensitive…

    • 794 Words
    • 4 Pages
    Improved Essays
  • Brilliant Essays

    . Reference list Allen, A. 2009. Privacy and medicine [Online]. Available from: http://plato.stanford.edu/entries/privacy-medicine/ [Accessed 04 November 2010].…

    • 1344 Words
    • 6 Pages
    Brilliant Essays
  • Improved Essays

    Utilitarianism is an ends-based method of ethical analysis. Rather than attempting to apply a code of moral behavior to the public, this approach focuses on the cost-benefit analysis (Blume and Heineman, 2007) of a policy and underscores its usefulness based on the overall outcome in society. In the case of medical conflicts of interests, the utility of the new policy centers on the creation of consumers that are more informed and the possibility for its largely positive outcome. The primary ethical dilemma presented within Austin Frakt’s article is that of the importance of the disclosure of all potential biases when discussing and applying merit to pharmaceutical and medical research.…

    • 613 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    The core of the pharmaceutical industry problems consists of the expiration of patents, rising R&D expenses, and uncertainties facing new researched products and their abnormal methods of circulation of returns from said product. As rooted in the topic of this case AstraZeneca upholds the gold of innovatively changing the way medicine reaches patients. When patents are first granted there are procedures that followed before a drug reaches the marketplace. Due to the extended timeframe that is required for clinical trials, studies and organizational processes to tested and developed the revenue phase of the drug decreases (Hitt, Ireland, & Hoskisson, 2015). More specifically after the developed drug is ready for sale the patent remaining on these products are near expiration.…

    • 703 Words
    • 3 Pages
    Improved Essays